Dr Hugo Tan

Dr Hugo joined BAT in February 2022 and is a trained medical physician who holds an active annual practicing license from the Malaysia Medical Council. After practicing in both major public and private hospitals in Kuala Lumpur, he spent 14 years in medical affairs for multinational pharmaceutical organizations such as GlaxoSmithKline, Merck KGA, Novo Nordisk, Takeda. Hugo was formerly Medical and Regulatory Director for Novartis Oncology and AstraZeneca Hong Kong. He has worked with leading researchers in early and late phase clinical trials and partnered with biotech start-ups to bring innovative medicine from early development to commercialization. Hugo also completed an MBA from the Manchester Business School